We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
TOBETA-XL; TOPRELOC-XL (Pharmacor Pty Ltd)
Product name
TOBETA-XL; TOPRELOC-XL
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
190 (255 working days)
Active ingredients
metoprolol/metoprolol succinate
Registration type
New generic medicine
Indication
TOBETA-XL; TOPRELOC-XL (modified release tablet) is indicated as a treatment for stable, chronic heart failure as an adjunct to other heart failure therapy.